or Try an Advanced Search...

    Diabetic Nephropathy Stocks List

    Symbol Grade Name % Change
    AMPE F Ampio Pharmaceuticals, Inc. -4.56
    BMY F Bristol-Myers Squibb Company 0.17
    CYCN D Cyclerion Therapeutics, Inc. 4.23
    INCY F Incyte Corporation 1.39
    LABP B Landos Biopharma, Inc. 2.23
    MESO C Mesoblast Limited -0.25
    XRTX F XORTX Therapeutics Inc. -0.38
    ZVSA F ZyVersa Therapeutics, Inc. 0.23
    View As Page of Charts
    Related Industries: Biotechnology Data Storage Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Kidney Disease Medicine Organ Systems Rheumatoid Arthritis Autoimmune Disease Diabetes Heart Failure Inflammation Inflammatory Conditions Kidney Life Sciences S&P 500 Abdominal Pain Adult Stem Cell Alport Syndrome Antioxidant Atrial Fibrillation Autosomal Dominant Polycystic Kidney Disease Back Pain

    Related ETFs - A few ETFs which own one or more of the above listed Diabetic Nephropathy stocks.

    Symbol Grade Name Weight
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 7.34
    MEDX D Horizon Kinetics Medical ETF 4.71
    WBIY C WBI Power Factor High Dividend ETF 4.16
    XPH D SPDR S&P Pharmaceuticals ETF 3.88
    IHE D iShares U.S. Pharmaceutical ETF 3.84
    View all Diabetic Nephropathy ETFs...
    Compare ETFs
    Compare FTXH to XPH Compare MEDX to XPH Compare XPH to IHE

        Diabetic Nephropathy Stocks Recent News

        Date Stock Title
        May 22 BMY Bristol-Myers Squibb snaps six days of losses, trades in the green
        May 22 BMY Bristol-Myers, Sanofi liability in Hawaii Plavix litigation tops $900M
        May 22 BMY Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M
        May 22 BMY Pfizer to Cut Costs in Multi-Year Effort
        May 22 BMY Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
        May 22 BMY Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million
        May 22 BMY Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries
        May 22 BMY Bristol-Myers Squibb Announces Strategies to Improve Access to Medicines
        May 22 BMY NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb
        May 22 BMY Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
        May 21 ZVSA Peering Into ZyVersa Therapeutics's Recent Short Interest
        May 21 INCY Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings
        May 21 BMY Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
        May 21 BMY 1 Stock I Wouldn't Touch With a 10-Foot Pole
        May 21 BMY Bristol-Myers says FDA has revised decision date on injected Opdivo
        May 21 BMY Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
        May 18 BMY Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%
        May 17 BMY AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
        May 17 INCY Here's Why Incyte (INCY) Stock is Up More Than 7% in a Week
        May 17 MESO Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
        Related Industries: Biotechnology Data Storage Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Kidney Disease Medicine Organ Systems Rheumatoid Arthritis Autoimmune Disease Diabetes Heart Failure Inflammation Inflammatory Conditions Kidney Life Sciences S&P 500 Abdominal Pain Adult Stem Cell Alport Syndrome Antioxidant Atrial Fibrillation Autosomal Dominant Polycystic Kidney Disease Back Pain
        Diabetic Nephropathy

        Diabetic nephropathy is a type of kidney disease that is caused by damage to the blood vessels in the kidneys due to diabetes. It is a serious complication of diabetes and can lead to kidney failure. Symptoms of diabetic nephropathy include high blood pressure, swelling in the legs and feet, and protein in the urine. Treatment for diabetic nephropathy includes controlling blood sugar levels, taking medications to reduce blood pressure, and following a healthy diet.

        Browse All Tags